Impact of the COVID‐19 pandemic on cytology practice: An international survey in the Asia‐Pacific region

Abstract

The results of the survey demonstrated that the COVID-19 pandemic resulted in a significant reduction in the number of cytology specimens examined along with the need to implement new biosafety protocols. These findings underscore the need for the worldwide standardization of biosafety protocols and cytology practice.